Cancer Institute A national cancer institute
designated cancer center

Willard ("Bill") E. Fee, Jr.

Publication Details

  • TRANSDERMAL SCOPOLAMINE IN THE TREATMENT OF ACUTE VERTIGO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY BABIN, R. W., Balkany, T. J., Fee, W. E. 1984; 93 (1): 25-27

    Abstract:

    A double-blind, parallel investigation was undertaken to evaluate the efficacy of transdermally delivered scopolamine hydrobromide in acute vertigo as compared to meclizine hydrochloride and placebo. Statistical analysis of subjective patient responses and clinical observations suggested that both scopolamine and meclizine are more effective than placebo. Both have significant, but different, side effects.

    View details for Web of Science ID A1984SE27000006

    View details for PubMedID 6703595

Stanford Medicine Resources:

Footer Links: